The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Headline
The Administration for Strategic Preparedness and Response has released a new cybersecurity module for organizations to conduct risk assessments. The free…
Perspective
Public
As the world has learned in recent years, today’s conflicts are fought with many weapons, and cyber warfare is an integral part of the arsenal.As of this…
Headline
The FBI is reminding critical infrastructure organizations to implement mitigations from a June 2025 fact sheet on potential actions by Iranian-affiliated…
Headline
The Cybersecurity and Infrastructure Security Agency Feb. 26 released a report that updates findings from last year on RESURGE malware used to gain covert…
Headline
U.S. and international agencies Feb. 25 released guidance on protecting Cisco Software-defined Wide-area Networking systems from exploitation by malicious…
Headline
The National Security Agency has released two phases of its Zero Trust Implementation Guidelines for organizations to improve their zero trust architecture.…